β-cell function:: A key pathological determinant in polycystic ovary syndrome

被引:82
作者
Goodarzi, MO
Erickson, S
Port, SC
Jennrich, RI
Korenman, SG
机构
[1] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA
[3] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
关键词
D O I
10.1210/jc.2004-1006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report data from 60 patients with polycystic ovary syndrome ( PCOS) who had undergone assessment of insulin resistance, pancreatic beta-cell function, obesity, and androgen levels to elucidate the complex relationships among these traits. Homeostasis model assessment was used to quantify insulin resistance and beta-cell function. A reference population was derived from the National Health and Nutrition Examination Study ( NHANES III, 1988 - 1994). Indices of insulin resistance, insulin secretion, bioavailable testosterone, and body mass index all exhibited significant pairwise correlations. Multiple regression analysis clarified the phenotypic relationships, demonstrating that insulin resistance and bioavailable testosterone were independent predictors of beta-cell function; beta-cell function and obesity were independent predictors of insulin resistance; and beta-cell function was an independent predictor of bioavailable testosterone. Of note, comparison with normal women from NHANES revealed a significantly stronger relationship between beta-cell function and insulin resistance in PCOS, raising the possibility of an intrinsic defect in beta-cell function whereby increasing insulin resistance leads to a greater insulin response in PCOS than normal. The altered relationship of beta-cell function and insulin resistance coupled with the fact that beta-cell function, not insulin resistance, was a predictor of hyperandrogenemia suggests that beta-cell dysfunction may be a key pathogenic determinant in PCOS.
引用
收藏
页码:310 / 315
页数:6
相关论文
共 49 条
[1]  
[Anonymous], 1996, 3 NAT HLTH NUTR EX S
[2]   Glucose intolerance in obese adolescents with polycystic ovary syndrome:: Roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease [J].
Arslanian, SA ;
Lewy, VD ;
Danadian, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :66-71
[3]   A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J].
Asunción, M ;
Calvo, RM ;
San Millán, JL ;
Sancho, J ;
Avila, S ;
Escobar-Morreale, HF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2434-2438
[4]   NONCLASSIC ADRENAL-HYPERPLASIA - CURRENT CONCEPTS [J].
AZZIZ, R ;
DEWAILLY, D ;
OWERBACH, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (04) :810-815
[5]   INSULIN STIMULATES ANDROGEN ACCUMULATION IN INCUBATIONS OF OVARIAN STROMA OBTAINED FROM WOMEN WITH HYPERANDROGENISM [J].
BARBIERI, RL ;
MAKRIS, A ;
RANDALL, RW ;
DANIELS, G ;
KISTNER, RW ;
RYAN, KJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (05) :904-910
[6]   Accurate assessment of β-cell function -: The hyperbolic correction [J].
Bergman, RN ;
Ader, M ;
Huecking, K ;
Van Citters, G .
DIABETES, 2002, 51 :S212-S220
[7]   Polycystic ovary syndrome (PCOS): Arguably the most common endocrinopathy is associated with significant morbidity in women [J].
Carmina, E ;
Lobo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06) :1897-1899
[8]   INSULIN RESISTANCE IN NON-OBESE PATIENTS WITH POLYCYSTIC OVARIAN DISEASE [J].
CHANG, RJ ;
NAKAMURA, RM ;
JUDD, HL ;
KAPLAN, SA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (02) :356-359
[9]   Acute insulin response to intravenous glucagon in polycystic ovary syndrome [J].
Ciampelli, M ;
Fulghesu, AM ;
Murgia, F ;
Guido, M ;
Cucinelli, F ;
Apa, R ;
Caruso, A ;
Lanzone, A .
HUMAN REPRODUCTION, 1998, 13 (04) :847-851
[10]   Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome [J].
Ciampelli, M ;
Fulghesu, AM ;
Cucinelli, F ;
Pavone, V ;
Caruso, A ;
Mancuso, S ;
Lanzone, A .
HUMAN REPRODUCTION, 1997, 12 (09) :1897-1901